Thirty-two outpatients with a mean age of 68 years were observed in a naturalistic study of outpatient electroconvulsive therapy (ECT) for the management of recurrent mood disorder. Sixty-nine percent of the patients responded favorably to ECT and were either discharged well from therapy or continue in treatment. A rehospitalization rate of 9% supports the efficacy of this treatment. We find outpatient ECT safe for the long-term management of recurrent depressive illness in elderly patients. The low dropout rate demonstrates that patient acceptance is equal to that of other outpatient treatments.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics of Inpatients with Schizophrenia Spectrum Disorder Treated with Electroconvulsive Therapy: A Population-Level Cross-Sectional Study: Titre: Caractéristiques cliniques des patients hospitalisés présentant un trouble du spectre de la schizophrénie et traités par électrochocs : Une étude de population transversale.
Can J Psychiatry
November 2024
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Objective: Electroconvulsive therapy (ECT) is an evidence-based treatment for schizophrenia when anti-psychotic medications do not sufficiently control symptoms of psychosis or rapid response is required. Little is known about how it is used in routine clinical practice. The aim of this study was to identify the association of demographic and clinical characteristics with administration of ECT for schizophrenia spectrum disorders (SSD).
View Article and Find Full Text PDFIntravenous ketamine successfully treats treatment-resistant catatonia in schizophrenia: A case report.
Pharmacotherapy
October 2024
Houston Methodist Hospital, Houston, Texas, USA.
Article Synopsis
- Benzodiazepines and ECT are primary treatments for catatonia, which can arise from psychiatric or medical conditions, but when they're ineffective, ketamine has been explored as an alternative therapy.
- A case study highlighted a 77-year-old woman with treatment-resistant catatonia due to schizophrenia, who showed a rapid recovery after a single ketamine infusion when ECT was unavailable during the pandemic.
- While ketamine may be a promising option for drug-resistant catatonia, it needs to be used carefully because it could potentially worsen psychosis in patients with schizophrenia, indicating the need for more research in this area.
Longitudinal Symptom Burden and Pharmacologic Management of Catatonia in Autism with and without Profound Impairment: An Observational Study.
medRxiv
September 2024
Department of Psychiatry, Harvard Medical School, 24 Shattuck Street, Boston, Massachusetts, 02115.
Introduction: Catatonia is a highly morbid psychomotor and affective disorder which can affect autistic individuals with and without profound impairment. Catatonic symptoms are treatable with pharmacotherapy and electroconvulsive therapy, but the longitudinal effectiveness of these treatments has not been described.
Methods: We conducted a prospective observational cohort study of patients with autism and co-morbid catatonia who received outpatient care in a specialized outpatient clinic from July 1, 2021 to May 31, 2024.
Evaluating cognitive assessment tools for patients with major depressive disorder receiving electroconvulsive therapy: A systematic review and meta-analysis.
Asian J Psychiatr
October 2024
School of Nursing, Peking University, Beijing, China. Electronic address:
Background: Major Depressive Disorder (MDD) affects 350 million people worldwide. Electroconvulsive therapy (ECT) is effective, yet research on cognitive assessments post-treatment is lacking. This study systematically reviews and meta-analyzes the effectiveness of cognitive assessment tools post-ECT to optimize MDD treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!